Longtime cannabis risk management executive Rocco Petrilli argues that cannabis-business risk management has not matured at the same rate as the cannabis industry at large. (Credit: Alona/Adobe Stock)
While trying to predict federal regulatory moves is like looking into a foggy crystal ball, Washington, D.C. insiders report that 2024 may be the year that the U.S. Justice Department recommends the removal of cannabis from the list of Schedule I drugs.
Want to continue reading?
Become a Free PropertyCasualty360 Digital Reader
Your access to unlimited PropertyCasualty360 content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- All PropertyCasualty360.com news coverage, best practices, and in-depth analysis.
- Educational webcasts, resources from industry leaders, and informative newsletters.
- Other award-winning websites including BenefitsPRO.com and ThinkAdvisor.com.
Already have an account? Sign In
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
Elana Ashanti Jefferson
Elana Ashanti Jefferson serves as ALM's PropertyCasualty360 Group Chief Editor. She is a veteran journalist and communications professional. Reach her by sending an e-mail to [email protected].
